These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38675723)

  • 21. Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor.
    Zhang Z; Guo Y; Chen M; Chen F; Liu B; Shen C
    Inflammopharmacology; 2021 Oct; 29(5):1587-1601. PubMed ID: 34322786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic insights into xanthomicrol as the active anti-HCC ingredient of Phytolacca acinosa Roxb.: A network pharmacology analysis and transcriptomics integrated experimental verification.
    Liu J; Zhou Y; Zhou P; He T; Liu P; Wang J; Lin P; Hou J; Sun H; Ma H
    J Ethnopharmacol; 2024 Oct; 333():118467. PubMed ID: 38909826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant Melanoma.
    Makhmalzadeh BS; Molavi O; Vakili MR; Zhang HF; Solimani A; Abyaneh HS; Loebenberg R; Lai R; Lavasanifar A
    J Pharm Pharm Sci; 2018; 21(1):143-159. PubMed ID: 29789104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology.
    Zheng J; Xu W; Liu W; Tang H; Lu J; Yu K; Song X; Li F; Wang Y; Wang R; Chen L; Zhang H; Qiu Y; Wei G; Zhou X; Yang J
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34002799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment.
    Wang K; Miao X; Kong F; Huang S; Mo J; Jin C; Zheng Y
    Drug Des Devel Ther; 2021; 15():3749-3764. PubMed ID: 34511884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
    Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
    J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
    Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DP from Euphorbia fischeriana S. mediated apoptosis in leukemia cells via the PI3k/Akt signaling pathways.
    Ma L; Chen Z; Li J; Zhang H; Jia Y; Liu J
    J Ethnopharmacol; 2021 Oct; 279():113889. PubMed ID: 33524514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
    Singh RP; Gu M; Agarwal R
    Cancer Res; 2008 Mar; 68(6):2043-50. PubMed ID: 18339887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of Tetrandrine Against Endometrial Cancer Based on Network Pharmacology.
    Shang W; Zhang J; Song H; Zhu S; Zhang A; Hua Y; Han S; Fu Y
    Drug Des Devel Ther; 2021; 15():2907-2919. PubMed ID: 34262258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria.
    Zeng J; Sun Y; Wu K; Li L; Zhang G; Yang Z; Wang Z; Zhang D; Xue Y; Chen Y; Zhu G; Wang X; He D
    Mol Cancer Ther; 2011 Jan; 10(1):104-16. PubMed ID: 21220495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of anti-cancer potency of silibinin on murine renal carcinoma RenCa cells in an animal model with an intact immune system.
    Yang C; Li F; Ma J; Zhang HB; Jia J; Zeng J; Wang X; He D; Guo P
    Anticancer Drugs; 2020 Sep; 31(8):785-791. PubMed ID: 32209841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ophiopogonin‑B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways.
    Yuan F; Gao Q; Tang H; Shi J; Zhou Y
    Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
    Liu Y; Xie X; Hou X; Shen J; Shi J; Chen H; He Y; Wang Z; Feng N
    J Nanobiotechnology; 2020 May; 18(1):83. PubMed ID: 32473632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation.
    Zhang Y; Yao Y; Fu Y; Yuan Z; Wu X; Wang T; Hong Z; Yang Y; Wu H
    J Ethnopharmacol; 2021 Oct; 278():114267. PubMed ID: 34087401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. rAj-Tspin, a novel recombinant peptide from Apostichopus japonicus, suppresses the proliferation, migration, and invasion of BEL-7402 cells via a mechanism associated with the ITGB1-FAK-AKT pathway.
    Yu P; Wu R; Zhou Z; Zhang X; Wang R; Wang X; Lin S; Wang J; Lv L
    Invest New Drugs; 2021 Apr; 39(2):377-385. PubMed ID: 32989643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway.
    Ren S; Xing Y; Wang C; Jiang F; Liu G; Li Z; Jiang T; Zhu Y; Piao D
    Int J Biochem Cell Biol; 2020 Aug; 125():105777. PubMed ID: 32504672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
    J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silibinin induces apoptosis through inhibition of the mTOR-GLI1-BCL2 pathway in renal cell carcinoma.
    Ma Z; Liu W; Zeng J; Zhou J; Guo P; Xie H; Yang Z; Zheng L; Xu S; Wang X; Chang LS; He D; Li L
    Oncol Rep; 2015 Nov; 34(5):2461-8. PubMed ID: 26323996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silibinin inhibits glioma cell proliferation via Ca2+/ROS/MAPK-dependent mechanism in vitro and glioma tumor growth in vivo.
    Kim KW; Choi CH; Kim TH; Kwon CH; Woo JS; Kim YK
    Neurochem Res; 2009 Aug; 34(8):1479-90. PubMed ID: 19263218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.